Jiménez, Jhancy Rocío Aguilar 
; Pelissari, Daniele Maria ; Diaz-Quijano, Fredi Alexander Diaz
Source: Tropical Medicine & International Health. Unidade: FSP
Subjects: TUBERCULOSE, DIAGNÓSTICO, MEDICAMENTO, ACESSO AOS SERVIÇOS DE SAÚDE, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JIMÉNEZ, Jhancy Rocío Aguilar e PELISSARI, Daniele Maria e DIAZ-QUIJANO, Fredi Alexander Diaz. How has the municipal availability of the GeneXpert® MTB/RIF system affected the detection of drug-resistant tuberculosisin Brazil?. Tropical Medicine & International Health, v. 29, n. 1, p. 57-62, 2023Tradução . . Disponível em: https://doi.org/10.1111/tmi.13945. Acesso em: 05 out. 2024.APA
Jiménez, J. R. A., Pelissari, D. M., & Diaz-Quijano, F. A. D. (2023). How has the municipal availability of the GeneXpert® MTB/RIF system affected the detection of drug-resistant tuberculosisin Brazil? Tropical Medicine & International Health, 29( 1), 57-62. doi:10.1111/tmi.13945NLM
Jiménez JRA, Pelissari DM, Diaz-Quijano FAD. How has the municipal availability of the GeneXpert® MTB/RIF system affected the detection of drug-resistant tuberculosisin Brazil? [Internet]. Tropical Medicine & International Health. 2023 ;29( 1): 57-62.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/tmi.13945Vancouver
Jiménez JRA, Pelissari DM, Diaz-Quijano FAD. How has the municipal availability of the GeneXpert® MTB/RIF system affected the detection of drug-resistant tuberculosisin Brazil? [Internet]. Tropical Medicine & International Health. 2023 ;29( 1): 57-62.[citado 2024 out. 05 ] Available from: https://doi.org/10.1111/tmi.13945
